The enhanced expression of CCL2 was reported in many types of cancer, including multiple myeloma, melanoma, esophageal, gastric, colorectal, lung, breast, ovary, and prostate cancer [30,34]. This evidence concerns the gene CCL2 and Familial prostate cancer.